- $120.95m
- $107.23m
- $2.04m
Humacyte Inc expected to post a loss of 19 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-AIG, Corcept Therapeutics, Dow
Humacyte Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Humacyte Q4 Operating Income USD -28.088 Million Vs. IBES Estimate USD -29.9 Million
U.S. RESEARCH ROUNDUP- Advanced Micro Devices, Carmax, Lockheed Martin
U.S. STOCKS ON THE MOVE-SurgePays, B. Riley, CarMax
U.S. STOCKS ON THE MOVE-OrganiGram, Phillips 66, SurgePays
U.S. STOCKS ON THE MOVE-Chewy, V2X, Cintas
Brief: Humacyte To Present Fourth Quarter And Full Year Financial Results And Provide Corporate Update On March 28, 2025
U.S. STOCKS ON THE MOVE-Dollar Tree, GameStop, Humacyte
Humacyte tumbles on pricing $50 mln stock offering
Brief: Humacyte Prices Public Offering Of 25 Million Shares At $2.00 Per Share
Humacyte tumbles on planned equity raise
Brief: Humacyte Announces Proposed Public Offering Of Common Stock
Humacyte Inc expected to post a loss of 25 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Spire, Copper miners, Abercrombie & Fitch
Brief: FDA Approves First Acellular Tissue Engineered Vessel To Treat Vascular Trauma In Extremities
U.S. STOCKS ON THE MOVE-Mission Produce, Sirius XM, Carnival Corp
U.S. STOCKS ON THE MOVE-Humacyte, Ionis Pharmaceuticals, Emeren Group